Nektar Therapeutics (NKTR) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $71.00 +0.32%
EPS Growth %: +26.6%
Financial Fact:
Income (loss) from operations: -32.9M
Today's EPS Names:
TIPT, NHTC, AMRN, More
EPS Growth %: +26.6%
Financial Fact:
Income (loss) from operations: -32.9M
Today's EPS Names:
TIPT, NHTC, AMRN, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q2 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $21.79 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parsons Corporation (PSN) Tops Q2 EPS by 10c; Offers Guidance
- ADP (ADP) Tops Q4 EPS by 5c; offers outlook
- Boston Scientific (BSX) PT Lowered to $60 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
